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25 Years of Laser Assisted Vascular Anastomosis (LAVA):
What Have We Learned?
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Objectives. Laser assisted vascular anastomosis (LAVA) has been developed to a stage where clinical use is within reach.
Advantages of LAVA are minimal vessel damage, faster operation and the potential for minimally invasive application.
Design. A Medline literature search was performed on vessel welding combined with cross-referencing.
Results. Four different lasers have mostly been used for LAVA, always in combination with stay sutures. The CO2 laser has
only been used in the early period. Without solder, mean leaking point pressures (LPP) of 754 mmHg (n ¼ 75) were obtained,
only slightly lower than in suture controls (LPP ¼ 915 mmHg, n ¼ 82). At follow-up the percentage of aneurysms was high
(overall 12% in n ¼ 486). Although Argon LAVA showed moderate success (LPP ¼ 146 mmHg, n ¼ 125), the first clinical
application has been successfully performed. Diode LAVA in combination with solder and dye resulted in an acceptable LPP
of 409 mmHg (n ¼ 163) in larger vessels, with a low incidence of aneurysm formation (1% in n ¼ 107).
Conclusion. At present the diode laser is the most popular. Solder developments resulted in stronger welds and might make
stay sutures redundant. The combination of CO2 laser and solders has not been evaluated and deserves further investigation.
Key Words: Laser assisted vascular anastomosis; Tissue welding; Review; Solder; Leaking point pressure.
Introduction
During the last decades there has been an increased
interest in minimally invasive surgery. In vascular
surgery, as in other areas of surgery, techniques are
refined that either require smaller incisions, less or
even no dissection at all.
The use of staples or clips in vascular anastomoses
works fast but is usually more traumatic to the vessel
than conventional sutures. Partly, this is due to the
considerable force necessary for bending clips or
staples. Other disadvantages include the limited size
and high cost. Fibrin glues and cyanoacrylate glues are
easy to apply and time saving. They do, however,
necessitate the use of additional sutures in order to
prevent aneurysm formation. More important, they
can give rise to allergic reactions and anaphylaxis.
Extra luminal rings seem suitable in cardiac surgery, in
vascular surgery, however, one might encounter
problems due to diameter mismatch. Also there are
only a limited number of ring diameters available. The
main disadvantage of intraluminal stents for vascular
anastomosis is the low patency rate found. A detailed
review on these alternative suture techniques is
provided by Zeebregts et al.1
Since the 1970’s, research has been performed on
laser welding.2 In laser welding energy from the laser
typically causes an alteration in protein structure of
tissues, resulting in repair through cross bonding of
proteins. One of the disadvantages of sutured anasto-
moses is the reaction of the vessel wall to the foreign
suture material. This foreign body reaction of intima
and media might contribute to myointimal hyperpla-
sia.3 In laser assisted vascular anastomosis (LAVA)
fewer or optimally no sutures are needed. If at the
same time thermal damage to the intima and media
caused by the laser energy can be prevented one might
expect less intimal hyperplasia at the site of the
anastomosis.4 In contrary to other alternative tech-
niques, diameter mismatch and toxic reactions are no
issue in LAVA. Coaptation of vessel walls, however, is
important. Ideally there should be perfect alignment of
intima against intima without bulging of wrinkling.
Various lasers have been used for LAVA. These
lasers have been used in combination with different
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kinds of protein solutions used as solders and/or dyes
in order to create an anastomosis of sufficient strength
to withstand physiologic variations in blood pressure.
At present, although research has been going on for 25
years, few clinical applications have been employed.
In this review, we discuss the various lasers that have
been used for LAVA, the use of solder and dye and
results of LAVA. Present clinical applications are
discussed, together with future possibilities and
limitations. Although publications dealing with
LAVA sometimes refer to laser assisted vessel repair
(LAVR) or laser assisted micro vessel anastomosis
(LAMA), we use the term LAVA in this review.
Methods
Via PubMed a Medline literature search (period June
1966–December 2002) was performed (http://www.
ncbi.nih.gov/entrez/query.fcgi). Keywords used
were: laser, tissue, welding, vascular anastomosis
and solder. This was combined with cross-referencing
from the reference lists of all recovered and relevant
publications on this subject. In total, 247 publications
were recovered, of which 70 were relevant. Non
relevant publications mostly concerned laser welding
in areas other than vascular surgery.
Lasers used in LAVA
In tissue, laser light can be reflected, absorbed,
scattered or transmitted, absorption being the most
important interaction in LAVA. Absorption of laser
light results in heating of tissue and subsequent
denaturation and cross bonding of proteins. The
balance between over- and underexposure of tissue
is critical. At a given wavelength the absorption of
laser energy varies within different tissues. In the
visible wavelength, light will predominantly be
absorbed in blood, whereas in the infrared wavelength
absorption predominantly occurs in water. Each tissue
has its own wavelength specific absorption coefficient.
Tissue absorption, scattering and the predominant
direction of scattering determine the penetration
depth of a laser. Penetration depth is defined as the
tissue depth at which the incident light intensity has
decreased by a factor of 1/e or to 36.8% of the incident
light. In the case of moderate to high tissue absorption,
it is likely that penetration should optimally be limited
to the adventitia to prevent reactive intimal hyperpla-
sia. Furthermore, local exposure should be sufficiently
short to prevent intimal damage by heat diffusion from
the adventitia. Consequently, tissue thickness is
another important factor to consider in laser welding.
In larger vessels the arterial wall or adventitia layer
will be thicker than in micro vessels, and thus deeper
penetration of laser light and heat is allowed and
required.
An increasing range of lasers with different wave-
lengths are available to medical science. Choosing a
certain wavelength for LAVA is, however, just a first
step, with so many other variables to choose from.
Irradiance or power density (by some authors also
called fluence) is the intensity of the laser light in terms
of power in Watts per unit area [W/cm2]. Radiant
exposure or energy density is the total energy of the
light per unit area [J/cm2]. One Joule equals one Watt
for one second. The fluence rate at a given point (in the
tissue) is the total power that passes through the
surface of an infinitesimally small sphere, centered on
that point, divided by the cross sectional area of the
sphere [W/cm2]. Multiplication of local fluence rate by
the time of exposure and local absorption coefficient
results in the local deposited energy [J/cm3]. The
deposited energy then converts into heat, resulting in a
local temperature increase that is responsible for the
tissue alterations.
Tissue compliance is important in obtained anasto-
motic tensile strength. Wall stress will be greater in the
larger vessels, according to LaPlace’s law, requiring
stronger welds in larger vessels. Obviously, for veins,
arteries or micro vessels differences in tissue compli-
ance and contractile properties should be considered.
Laser parameters important in determining the
interaction with tissue are wavelength, power, power
density and/or spot size, and time of exposure. The
lasers used for LAVA are the CO2 laser, the Neody-
mium: Ytrrium–Aluminum Garnet (Nd:YAG) laser,
the diode laser and the argon laser. Some of the
characteristics of these lasers are summarized in
Table 1.
Solder and dye
Solders have greatly contributed to optimising LAVA.
They consist of a protein or protein-like substance
applied to the weld to enhance bonding. Heating of
solder by laser irradiation results in denaturation of
proteins with subsequent cross-linking. Lying as a film
over the weld, solder will enlarge the bonding surface
of the weld, and thus increase the strength of the weld.
Solder also acts as a heat sink to reduce thermal
damage. It is also used for other applications of tissue
welding and thus solder research is extensive.5 – 8
Blood was the first substance used as a solder.9 Laser
energy was hypothesised to stimulate fibrin
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polymerisation, resulting in stronger welds.10 Fibrin
glue as an adjunct resulted in a reduction in primary
disruption of anastomoses and increased weld
strength.11 Later, solder consisted of different proteins
like egg albumin solder, humane albumin solder
(HAS),12,13 bovine serum albumin (BSA)13 or porcine
serum albumin (PSA)14 to be applied on the laser
weld.15 Results with laser assisted soldering were
significantly better than results without the use of
solder. However, the liquidity of the solder decreased
reproducibility as the thickness and surface area of the
fluid solder could not accurately be controlled. Since
then, several studies have investigated the use of
solder in solid form like membranes or strips.16 – 18 The
latest innovation consists of a light activated biode-
gradable solder polymer membrane consisting of
poly(L-lactic-co-glycolic acid) (PLGA).19 – 21
By adding a wavelength-specific chromophore or
dye to the welding site or solder, laser absorption is
greatly enhanced, allowing for more selective heating
of tissue with less injury to underlying tissues. The
addition of methylene blue (MB) when using the 800–
810 nm diode laser leads to selective heating of the
outer layers of the vessel wall, whereas thermal
damage to the inner layers will be minimalized. CO2
laser light is mostly absorbed in water, e.g. in the
solder solution. The predominant wavelength absorp-
tion listed in Table 1 illustrates the chromophores that
can be used in combination with the various lasers.
Results in the literature
In this review, publications regarding soldering of
slabs of vascular tissue are not included since these are
all preliminary studies. Fifty-seven retrieved publi-
cations dealt with laser assisted vascular anastomoses.
Only a limited number of papers22 – 25 reported full
details on laser settings such as laser wavelength,
continuous versus pulsed irradiation, spot size and
power or power density, exposure time or energy and
energy density, or enough details for calculation
thereof. Missing description of basic laser settings
such as spot size or total irradiation time resulted in
exclusion of the publication from this review. Some
publications reported on studies using a varying spot
size. Since power density is proportional to the
squared radius of the spot, small variations in spot
size greatly affect reproducibility and, therefore, this
was another reason for excluding a study. The same
applies to the used power. Variation in power in
combination with a small spot size leads to large
variation in power density. Schmiedt et al.26 for
instance accurately reported laser settings. However,Ta
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the spot size of 0.6 mm, power of 6.5–10.5 W and total
irradiation time of 2–4.5 s results in a variation of
approximately 3.6 in energy per mm weld. Unfortu-
nately, this variation makes the results irreproducible.
For this reason, papers with variations in calculated
energy/mm weld of more than an arbitrarily chosen
factor p are excluded.
Leaking point pressure
Table 2 gives an overview of publications on LAVA
focussing on leaking point pressure (LPP). LPP is a
measurement of anastomotic strength. The tested
segment is infused with a coloured saline solution
using a mechanical pump until leaking occurs, while
pressure (in mmHg) is continuously recorded. The
pressure at which leakage from the anastomosis is
seen, mostly concurring with a sudden drop in
pressure, or the peak pressure at which no further
rise in pressure is seen, is recorded as LPP. Some
authors tested anastomosis on tensile strength27 – 29
rather than LPP. In measuring tensile strength, vessels
are distracted while tension is measured. Unfortu-
nately, no clear endpoint of this test is defined in the
various papers, such as total rupture versus partial
rupture of the weld. Other authors report bursting
point pressures (BPP). In measuring BPP, a balloon is
inflated in the welded segment until literal bursting of
the weld occurs. However, some papers describe LPP
but name it BPP.14 These results are included in the
table. If a study mentions LPP’s measured at different
follow-up intervals only the value from the latest
follow-up moment, which is invariably the lowest
value, is given.
Various authors made use of a sutured control
group.30 – 39 These sutured control results are not
included in the table. These anastomoses were mostly
made with a continuous running suture. Overall, mean
LPP in the sutured control groups ðn ¼ 82Þ was
915 ^ 609 mmHg (range 127–2000 mmHg).33,36,37,39–45
Most reports of CO2 LAVA are on end-to-end micro
vascular anastomoses, with use of three to four stay
sutures. Measured LPP’s are all supra physiologic,
with a mean of 754 mmHg. Application of fibrin glue
to the weld11 resulted in even higher LPP’s up to
1008 mmHg. Welding of veins with a diameter of
8 mm without use of solder resulted in weak bonding
with a disruption rate as high as 50%.33 Application of
fibrin glue to the weld decreased the disruption rate to
18% and resulted in a LPP of 241 mmHg. Guo and
Chao46 tried CO2 LAVA without stay sutures and
measured LPP’s equal to those found in the group
with stay sutures. At follow-up however, aneurysms
were seen in 20% of their welds, whereas no
aneurysms were seen in the group with stay sutures.
This is attributed to poor coaptation of vessel edges in
the group without stay sutures.
Diode LAVA has mostly been performed on
arteriotomies. One paper reports on the use of a
diode laser at 1.950 mm47 (Author what UNITS). The
authors deliberately chose this wavelength because its
supposed penetration depth of 10 mm matches the
thickness of the rat aortic wall (according to us the
penetration depth of that laser should be approxi-
mately 1 mm in a bloodless vessel wall as estimated by
van Gemert and Welch48). Another paper reports on
the use of the diode laser at 670 nm.14 This wavelength
was chosen for its compatibility with methylene blue
(MB) as a chromophore. The choice for MB over other
available solders was because of its photo bleaching.
This phenomenon of clear discoloration of the chro-
mophore by laser irradiation gives the surgeon visual
feedback. Furthermore, the authors describe how this
photochemical bleaching will reduce absorption and
thus limit heat build-up in the vessel wall. This switch
in absorption would then prevent overexposure of
tissue. LPP’s measured in this study increase with
increasing concentration of MB in the solder, and
eventually reach 1188 mmHg.
Vessels used in 800–810 nm diode LAVA were of
intermediate size (diameter 2–7 mm). In comparison
with CO2 LAVA mean energy/mm weld is increased
by a factor 10–20. Obviously, tissue absorption is
much higher at CO2 LAVA vs. diode LAVA without
dye. Furthermore, bigger vessels have thicker vessel
walls, requiring more energy for sufficient tissue effect.
For this type of diode laser all authors make use of ICG
as a chromophore. Without the use of solder49 LPP’s
are considerably lower. Oz et al.37 performed diode
LAVA on modified umbilical vein grafts. Although
LPP’s were relatively low, they were not significantly
different from the LPP’s (127 mmHg) in his sutured
control group. Use of a solder doped membrane50
results in high LPP’s even in the absence of stay
sutures; it must be noted, however, that the authors
omitted to report the length of the arteriotomy.
Argon LAVA was used in four papers. Vlasak et al.51
explored a variety of power settings, and concluded
that to maximise strength of longer repairs, veno-
tomies should be welded at lower power settings than
arteriotomies. This difference in optimal power was
explained by the variable wall composition and
thickness of arteries and veins. The use of fluorescein
isothiocyanate dye by Chuck et al.52 did not result in
significantly higher LPP. The absence of solder in the
argon laser group has probably led to the somewhat
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Table 2. Publications reporting on LPP, sorted by type of laser and use of solder
Author V N Vessel used M # Total energy/mm weld
[J/mm]
Solder Follow-up
[days]
Patency
[%]
Leaking point pressure ^ SD
[mmHg]
CO2 laser at 10,600 nm
Basu72 þ 35 Rat fem. a. Ete 3 0.23* – 84 ? 365–2000
Basu73 þ 4 Dog mamm. a. Ets 4 ? – 0 100 348 ^ 8
Grubbs11 þ 12 Rat fem. a. Ete 3 0.25* – 1 – 366 ^ 84
þ 12 Rat fem. a. Ete 3 0.25* Fibrin glue 1 – 661 ^ 94
Cikrit33 þ 12 Dog jug. v. Ete 4 3.6 Fibrin glue 42 82 222 ^ 18–241 ^ 89
75 0.81 6 1.3 754 6 564
Vale35,74 þ 43 Rat car. a. Ete 3 0.13* – 180 93 .300
Guo43,75 þ 16 Rabbit saph. a. Ete – 0.11–0.21 – 84 100 .250
þ 24 Rabbit saph. a. Ete 3 0.11–0.21 – 84 93 .250
Diode laser at 1950 nm
Stewart47 þ 24 Rat aorta Tomy 2 0.15–0.24 – 0 ? 266 ^ 69
Diode laser at 800–810 nm
Oz49 þ 13 Rabbit aorta Tomy 2 1.9 – 0 100 159 ^ 45†
þ 10 Rabbit aorta Tomy 2 1.9 – 0 100 262 ^ 29‡
þ 9 Rabbit aorta Tomy 2 1.9 – 0 100 187 ^ 35§
Ott76 2 25 Pig tibial a. Ete – 11.6–29.3 BSA – ? 511 ^ 254
2 16 Pig saph. v. Ete – 11.6–29.3 BSA – ? 238 ^ 153
Oz36 þ 11 Rabbit aorta Tomy 2 1.29 0 100 262 ^ 29
þ 11 Rabbit aorta Tomy 2 1.29 Fibrinogen 0 100 330 ^ 75
þ 5 Rabbit aorta Tomy 2 1.29 Fibrinogen 0 100 290 ^ 74{
Oz37 2 8 Umbilical v. Tomy – 1.50 – – ? 39 ^ 8
2 19 Umbilical v. Tomy – 1.50 Fibrinogen – ? 112 ^ 55
Riley50 þ 24 Pig car./fem. a. Tomy – ? PLGA/PSA 3 100 817 ^ 160
þ 12 Pig car./fem. a. Tomy – ? PLGA/PSA 3 100 724 ^ 100k,
163 7.7 6 8.9 409 6 397
McNally20 þ 22 Dog car./fem. a. Tomy – 20.0–22.2 PLGA/PSA 1 92 70% . 250
þ 14 Dog fem. v. Tomy – 17.8 PLGA/PSA 1 86 50% . 250
Diode laser at 670 nm
Birch14 – 30 Pig splenic a. Ete 2 0.96 PSA – ? 250–1188 ^ 222
Argon laser at 488
or 514.5 nm
Vlasak51 þ 27 Dog car./fem. a. Tomy 2 30–144 – 0 ? 194 ^ 63–330 ^ 250
þ 27 Dog car./fem. a. Tomy 2 30–144 – 0 ? 44 ^ 10–114 ^ 66
þ 33 Dog fem./jug. v. Tomy 2 30–144 – 0 ? 95 ^ 55–193 ^ 123
þ 18 Dog fem./jug. v. Tomy 2 30–144 – 0 ? 41 ^ 30–132 ^ 57
Chuck52 þ 10 Rabbit aorta Tomy 2 0.86 – 0 100 164
þ 10 Rabbit aorta Tomy 2 1.7 – 0 100 147
125 64 6 38 146 6 70
Lawrence45,77 þ 52 Dog fem./car. a. Tomy 3 15 – 0 59 220– . 300
Chikamatsu39 þ 12 Dog ext. iliac a. Ete 4 0.35 – 150 100 .300
Overall 641 19 6 31 434 6 407
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disappointing mean LPP of 146 mmHg despite the
relatively large energy per mm weld.
Aneurysm formation
Table 3 summarises results of all papers that reported
on aneurysm formation in series with a follow-up
longer than one week (range 21–180 days). The
percentage of aneurysms reported in the CO2 laser
group is strikingly high (overall incidence of 12% in
n ¼ 486 welds). These aneurysms occur even in the
presence of stay sutures.
In the presence of solder, Nd:YAG and diode laser
assisted welding produce a vastly reliable weld.
However, disruptions do occur and in some papers
additional sutures are used for repairing leaky
welds.23,24 In diode LAVA an overall incidence of
aneurysms of 1% was seen ðn ¼ 107Þ:
Although all papers in Table 3 deal with histology,
unfortunately there is no uniformity in the reporting of
histological results. Furthermore, notes on one of the
most important clinical endpoints in vascular surgery,
intimal hyperplasia (IH), are rare. White et al.24
reported less IH at 8 weeks when compared to sutured
controls. When replacing the prolene stay sutures with
biodegradable sutures, intimal hyperplasia was even
less.23 Reendothelialisation of the anastomotic line was
seen within 1–6 weeks. Thermal damage, another
interesting aspect of histology, also remains under-
reported. The use of FITC in combination with the
argon laser decreased collateral thermal damage.52
Tissue coaptation
All but three authors make use of stay sutures. Bass
et al.53 made use of a silicone intraluminal stent for
diode LAVA on rat carotid arteries. With use of
fibrinogen and ICG end-to-end anastomoses were
performed. Rats were terminated one hour after
welding. At histology good coaptation was seen.
Unfortunately, no other work on this stent has been
published afterwards. He et al.54 made use of a
dissolvable stent consisting of a mixture of glyceride,
diglyceride and triglyceride. End-to-end anastomoses
on rat femoral arteries were then performed, however,
in addition to the stent two stay sutures were used.
After welding, melting of the stent was encouraged by
washing the welded site with 40 8C isotonic saline. All
of the 19 vessels were patent immediately after
welding. No long term follow-up is published at
present. Unfortunately, the potential benefit of this
stent in avoiding foreign body material is counteracted
by the two stay sutures used. Thirdly, Ott et al.55 inTa
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their recently published paper described the concept
of intravascular welding using a diode laser. A fibre
with a specially designed tip that allowed homo-
geneous 3608 irradiation of the vessel wall was used.
This fibre was inserted via a side branch in larger
vessels either in a glass tube or in a balloon catheter,
dependent on vessel size. Solder and dye were applied
on the outside after which irradiation was performed.
The authors found that the low absorption in the
vessel wall in combination with high penetration
depth allowed predominant absorption in the applied
solder and dye, resulting in a strong weld and limited
thermal damage. Obvious advantages of this promis-
ing new approach are almost perfect coaptation of the
vessel walls and homogeneous irradiation (Table 3).
Clinical application
Apart from animal studies three papers dealt with
clinical application of LAVA. Jain56 was far ahead of
his time and performed Nd:YAG laser assisted extra-
intracranial bypass operations on five patients in the
early 80’s. At a set power of 18 W and without any stay
sutures an end-to-side anastomosis was made. After
follow-up of 6–9 months all five patients were alive
with angiographic patent anastomoses. In the late
eighties, White et al. described a series of 10 patients
receiving laser assisted arteriovenous fistulas for
haemodialysis.57 Radiocephalic anastomoses of 1.2–
1.5 cm length were fused using argon laser and four
stay sutures. Four patients needed revision operations
after 4–6 months and one patient died, resulting in a
primary patency of 50% at a median follow-up of 15
months. Finally, Okada et al.58 report on various
clinical experiments using a CO2 laser. Arterial and
venous reconstructions for a variety of indications
were performed. Since, the reported results are highly
unlikely the paper will not be discussed here.
Discussion
Over the years LAVA has developed to a stage where
clinical use is within reach. Lasers have been refined
and are more readily available, at lower cost. Aneur-
ysm formation is one of the main reasons for the
passing into disuse of the CO2 laser. Some authors
even see CO2 LAVA suitable for producing a reliable
aneurysm model.59 Different theories are proposed for
the occurrence of aneurysm. For one, it is thought to be
the result of thermal damage to the internal elastic
lamina.60 Transmural injury and the inability to
properly regenerate the loss of elastic lamina allow
aneurysmal dilatation to occur in thin walled vessels.
Larger arteries have thicker vessel walls and will be
less prone to aneurysm formation. Since penetration of
laser energy will remain the same in these larger
vessels less thermal damage is likely to occur in the
internal elastic lamina. This could mean that welding
larger arteries may just safeguard against formation of
laser induced aneurysms.61 However, the mechanism
of aneurysm formation caused by thermal injury is
seen not only in the CO2 LAVA but in diode, Nd:YAG
and argon LAVA as well.52,62 – 64
Another mechanism of aneurysm formation might
be poor technique rather than thermal damage.65
Imprecise alignment of vessel edges leads to overlap-
ping or wide separation of vessel edges. Such a weld
will be relatively weak in the early postoperative
period. The use of stay sutures might then prevent
early disruption but aneurysm formation seems
inevitable. Innovations on vessel alignment may
replace stay sutures. Intraluminal coaptation tech-
niques seam suitable.53 – 55 The intimal damage pro-
duced by inserting the devices will be of temporary
nature, in contrast to stay sutures.
If anastomotic disruption occurs, subsequent
simple re-exposure to laser energy of disrupted
welds might not be adequate.66 This will cause welds
to be highly susceptible to aneurysm formation. It is
stated that twice the initial laser energy should be used
for repair of the disrupted weld in order to decrease
the risk of aneurysm formation afterwards.66 Whereas
techniques on LAVA can be and have been improved,
the issue of thermal damage is more difficult. Review-
ing the literature, however, it is striking that aneurysm
formation is only reported in papers discussing LAVA
without solder. Based on this review, we conclude that
the use of solder with or without chromophores will
lead to stronger welds, with less thermal damage, and
subsequent lesser aneurysm formation. We think most
improvements on LAVA in the future will be based on
solder improvement. At present, the combination of
diode laser, solder, dye and fabric seems most
promising. Not only will this enhance the strength of
the weld but it might also prove a valuable aid in
vessel coaptation without stay sutures. The combi-
nation hereof with the endoluminal lasering technique
might even further facilitate vessel alignment and
seems an attractive set-up for further research.
It is remarkable that in most recent studies diode
lasers are used in combination with solders, whereas
other wavelengths almost seem to have been forgot-
ten. Reports on CO2 LAVA are a rarity. It is, however,
striking that CO2 LAVA resulted in significantly higher
LPP’s than any other laser, even without solder. The
shallow penetration of this laser in combination with
I. C. D. Y. M. Wolf -de Jonge et al.472
Eur J Vasc Endovasc Surg Vol 27, May 2004
Table 3. Results on LAVA with regard to aneurysm formation
Author N Vessel used M # Total energy/mm weld [J/mm] Solder Dye Follow-up [days] Patency L/S [%] Aneurysms L/S [%]
CO2 laser at 10,600 nm
Vale78 43 Rat car. a. Ete 3 0.13* – – 180 93/98 12/0
Neblett79 212 Rat fem. a. Ete 3 0.1 – – 180 95/96 7/13
White67 4 Dog fem. v. Tomy 1 1.1 – – 21 100/– 0/–
Ashworth80 12 Dog car. a. Ete 4 0.05 – – 42 100/92 0/0
Guo81 16 Rabbit saph. a. Ete 0 0.11–0.21 – – 84 100/– 20/–
24 Rabbit saph. a. Ete 3 0.11–0.21 – – 84 93/93 0/0
Grubbs11 50 Rat fem. a. Ete 3 0.25* – – 21 94/– 36/–
25 Rat fem. a. Ete 3 0.25* Fibrin glue – 21 100/88 8/5
Frazier82 26 Pig jug. v. to car. a. Ets † 0.27 – – 150 73/– 12/–
Jacobowitz65 25 Rat fem. a. Ete 3 0.23 – – 21 92/– 30/–
25 Rat fem. a. Ete 3 0.23 – – 21 96/– 17/–
Cikrit33 10 Dog jug. v. Ete 4 3.6 – – 42 30/– 0/–
14 Dog jug. v. Ete 4 3.6 Fibrin glue – 42 82/93 0/0
Dalsing83 10 Dog car. a. Ete 4 2.2 – – 56 ? ?
Diode laser at 1900 nm
Lauto12 6 Dog car. a. Ete 3 3.6 HAS – 21 100/– ?
Nd:YAG laser at 1318 nm
White67 6 Dog fem. v. Tomy 1 1.8 – – 21 100/– 0/–
Shapiro84 22 Rat car. a. Ets 4 72* 182 86/– 23/–
Lauto12 4 Dog car. a. Ete 3 13 HAS – 21 75/– ?
Diode laser at 800–810 nm
Oz36 22 Rabbit aorta Tomy 2 1.3 Fibrinogen ICG 90 100/– 0/–
Tang85 70 Rat car. a. Ete 3 2.2 – – 90 93/93 1/1
Maitz27 15 Rat aorta Ete 0 0.22 BSA ring ICG 42 100/100 0/0
Diode laser at 670 nm
Birch86 15 Rabbit car. a. Ete 3 0.53 PSA MB 60 0/– 0/–
15 Rabbit car. a. Ete 3 0.26 PSA MB 60 93/– 0/–
Argon laser at 488 or 514.5 nm
White67 4 Dog fem./car. a. Tomy 4 12 – – 28 100/100 0/0
White87 5 Dog fem./car. a. Tomy 1 23–30 – – 35 80/– 0/–
White25 4 Dog fem. v. Tomy 1 6 – – 28 100/100 0/0
4 Dog fem. a. Tomy 1 6 – – 28 100/– 0/–
White24 10 Dog fem. av fistula Sts 4 12 – – 56 100/– 0/0
Godlewski64 50 Rat car. a. Ete 2 9.6 – – 120 76/– 10/–
Chuck52 18 Rabbit aorta Tomy 2 0.86 – FITC 75 100/– 0/–
7 Rabbit aorta Tomy 2 1.7 – – 75 100/– 14/0
White23 10 Dog fem. av fistula Sts 2‡ 4.4 – – 168 100/– 0/0
Chikamatsu39 12 Dog ext. iliac a. Ete 4 0.35 – – 150 100/100 0/0
Cursive numbers are calculated from the reported data. N; number of lasered anastomoses, total lasered anastomoses are in bold; M, method: arteriotomy (tomy), end-to-end (ete), end-
to-side (ets) or side-to-side (sts); #, number of stay sutures that have been used; Follow-up, longest follow-up period; A, aneurysms; L, lasered anastomoses; S, sutured control; HAS,
human albumin solder; BSA, bovine serum albumin; PSA, porcine serum albumin; ICG, indocyanine green; MB, methylene blue; FITC, fluorescein isothiocyanate. *, Pulsed irradiation.
†4–6 Sutures used, removal after completion of weld.
‡Absorbable sutures.
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(an enforced) solder seems perfect for a strong
anastomosis without thermal damage to the intimal
layer. Therefore, it would be worthwhile to restart CO2
LAVA in combination with the ‘new’ technique of
solders; it is to be expected that LPP’s will be high and
incidence of aneurysm formation will be dramatically
decreased.
Regarding results on LAVA in literature there is a
definite potential for clinical application. However, it
is disappointing that the description of materials and
methods in the majority of papers is of moderate
quality. For example, although pulsed versus continu-
ous irradiation and the used power are reported in
most papers, other details of exposure time, vessel
diameter and length of arteriotomy are missing. This
makes calculation of energy density and energy/mm
weld impossible parameters, which will ultimately
determine the outcome. Failure to report all relevant
parameters causes irreproducibility. Although most
authors make an effort to perform histology, most do
not report a descriptive analysis. The extent of thermal
damage and intimal hyperplasia should be described
by uniform scoring systems and incidence or absence
of aneurysm formation reported. In our opinion
testing of anastomosis should preferably be by
assessment of leaking point pressure. A reporting
standard on different aspects of LAVA is thus needed.
We conclude that LAVA is a promising technique
and in recent years considerable progress has been
achieved. Although clinical use at present is infre-
quent, experimental results warrant clinical appli-
cation and research in selected patients.
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